In today's article, Indo Search Director Josh Craven looks at what is new in MedTech and HealthTech during March.
Impact of extension of Medical Device Regulations transitional period and the validity of certificates in the EU.
The EU is introducing more time to certify certain medical devices under EU Medical Device Regulation (“EU MDR”). The proposal recognises the challenges in capacity across notified bodies.
However the advice from Regulatory and Quality Professionals to manufacturers in MedTech is this is not the time to take your foot off the gas, you will need everything ready by end of 2022 to get your QMS and Technical Documentation ready with your Notified Body.
IMed develops a guide to Post Market Surveillance.
IMed Consultancy, a regulatory and compliance consultancy provider with over 50 years of experience supporting UK and international medical device and in vitro device manufacturers to launch and maintain their products on global markets, has pooled in-house expertise to develop a free practical guide to Post Market Surveillance.
Industry reacts to the publication of UK MedTech Strategy.
The Department of Health and Social Care has published the first-ever medical technology strategy for the UK in a bid to accelerate access to innovative technologies.
London’s Spex Capital launches £88m health tech fund.
“With this fund, our partnership with MedCity, and a broad network of high calibre Senior Advisors, we will have unparalleled access to invest in the best startups within this space,” Claudio D’Angelo, founder and CEO of Spex Capital.
So far London-based Spex Capital, founded by Claudio D’Angelo, has made 10 investments. They include Skin Analytics, LiveSmart and MediShout.
New artificial intelligence and digital health resource published for the NHS.
The resource has been released by Health Education England (HEE) and looks to identify knowledge gaps amongst NHS staff whilst also setting out the path ahead for digital enablement in the healthcare workforce.
Apple's long-desired glucose tracking is reportedly at a proof-of-concept stage.
Bloomberg reported Wednesday that the tech giant has reached the proof-of-concept stage for sensor technology that could ultimately allow Apple Watch wearers with diabetes to monitor their blood sugar levels around the clock without requiring any skin-pricking for calibration or analysis.
Methinks receive CE-marked certification.
Digital health company Methinks - which specialises in the early detection and management of Acute Stroke by using artificial intelligence (AI) – has announced that it has received CE-marked certification for its medical imaging software, the Methinks Stroke Suite.
Congratulations to SureScreen Diagnostics, selected as a leading innovator by DIT.
One of the UK's biggest manufacturers of lateral flow tests is looking to access new markets all over the world after it was named a leading UK Life Sciences Innovator by the Department for International Trade (DIT).